# Transcutaneous Submandibular Gland Biopsy: Feasibility of Repeat Biopsy as a Progression Marker for Parkinson's Disease

> **NCT03359226** · NA · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 7 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **PROCEDURE:** Submandibular gland biopsy

## Key facts

- **NCT ID:** NCT03359226
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-21
- **Primary completion:** 2018-05-31
- **Final completion:** 2018-05-31
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2018-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359226, "Transcutaneous Submandibular Gland Biopsy: Feasibility of Repeat Biopsy as a Progression Marker for Parkinson's Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03359226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*